Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) dropped from S&P Pharmaceuticals Select Industry Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.19 USD | +0.85% | +1.71% | +13.33% |
05-07 | Transcript : Aclaris Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
05-07 | Earnings Flash (ACRS) ACLARIS THERAPEUTICS Reports Q1 Revenue $2.4M, vs. Street Est of $2M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.33% | 84.09M | |
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |
- Stock Market
- Equities
- ACRS Stock
- News Aclaris Therapeutics, Inc.
- Aclaris Therapeutics, Inc.(NasdaqGS: ACRS) dropped from S&P Pharmaceuticals Select Industry Index